Skip to Content

Dapagliflozin

In the US, Dapagliflozin (dapagliflozin systemic) is a member of the drug class SGLT-2 inhibitors and is used to treat Diabetes, Type 2.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BK01

CAS registry number (Chemical Abstracts Service)

0461432-26-8

Chemical Formula

C21-H25-Cl-O6

Molecular Weight

409

Therapeutic Category

Oral antidiabetic agent: sodium-glucose co-transporter 2 (SGLT2) inhibitor

Chemical Name

(1S)-1,5-anhydro-1-C-{4-chloro-3-[(4-etoxyphenyl)metyl]phenyl}-D-glucitol (WHO)

Foreign Names

  • Dapagliflozinum (Latin)
  • Dapagliflozin (German)
  • Dapagliflozine (French)
  • Dapagliflozina (Spanish)

Generic Names

  • Dapagliflozin (OS: USAN)
  • BMS-512148 (IS)
  • UNII-1ULL0QJ8UC (IS)
  • BMS 512148-05 (IS)
  • Dapagliflozin propanediol monohydrate (IS)
  • Dapagliflozin, mixture with propylene glycol, hydrate (IS)
  • UNII-887K2391VH (IS)

Brand Names

  • Ebymect [+ Metformin]
    AstraZeneca, Lithuania; AstraZeneca, Poland; AstraZeneca AB, Greece; Esteve, Spain
  • Edistride
    AstraZeneca, Lithuania; AstraZeneca AB, Greece; Esteve, Spain
  • Farxiga
    AstraZeneca, United States
  • Forxiga
    AstraZeneca, Australia; AstraZeneca, Chile; AstraZeneca, Colombia; AstraZeneca, Spain; AstraZeneca, Georgia; AstraZeneca, Hong Kong; AstraZeneca, Croatia (Hrvatska); AstraZeneca, Lithuania; AstraZeneca, Malaysia; AstraZeneca, Peru; AstraZeneca, Slovenia; AstraZeneca, Thailand; AstraZeneca AB, Cyprus; AstraZeneca Singapore, Vietnam; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Serbia
  • Forxiga 10mg
    AstraZeneca, Hungary; AstraZeneca, Luxembourg
  • Forxiga 5mg
    AstraZeneca, Hungary
  • Forziga
    AstraZeneca, Turkey
  • Qtern [+ Saxagliptin]
    AstraZeneca, Denmark; AstraZeneca, Lithuania; AstraZeneca, Latvia; AstraZeneca, Slovenia
  • Xigduo [+ Metformin]
    AstraZeneca, Brazil; AstraZeneca, Spain; AstraZeneca, Croatia (Hrvatska); AstraZeneca, Lithuania; AstraZeneca, Latvia; AstraZeneca, New Zealand; AstraZeneca, Slovenia; Bristol-Myers Squibb, Poland
  • Xigduo 5 mg/1000 mg [+ Metformin]
    AstraZeneca, Hungary
  • Xigduo 5 mg/850 mg [+ Metformin]
    AstraZeneca, Hungary
  • Xigduo 5mg/1000mg [+ Metformin]
    AstraZeneca, Luxembourg
  • Xigduo 5mg/850mg [+ Metformin]
    AstraZeneca, Luxembourg
  • Xigduo XR [+ Metformin]
    AstraZeneca, Turkey
  • Ebymect [+ Metformin]
    AstraZeneca, Estonia; AstraZeneca, Sweden; AstraZeneca AB, Netherlands
  • Edistride
    AstraZeneca, Estonia; AstraZeneca, Sweden; AstraZeneca AB, Netherlands
  • Forxiga
    2care4, Norway; Astra, Philippines; AstraZeneca, Argentina; AstraZeneca, Belgium; AstraZeneca, Canada; AstraZeneca, Czech Republic; AstraZeneca, Germany; AstraZeneca, Denmark; AstraZeneca, Estonia; AstraZeneca, Finland; AstraZeneca, Ireland; AstraZeneca, Japan; AstraZeneca, Netherlands; AstraZeneca, Norway; AstraZeneca, New Zealand; AstraZeneca, Portugal; AstraZeneca, Romania; AstraZeneca, Sweden; AstraZeneca AB, Iceland; AstraZeneca AE, Greece; AstraZeneca Singapore, Singapore; AstraZeneca UK, United Kingdom; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Slovakia; Farmagon, Norway
  • Forxiga 10mg
    AstraZeneca, Austria; AstraZeneca, Switzerland; AstraZeneca, Israel
  • Forxiga 5mg
    AstraZeneca, Austria; AstraZeneca, Switzerland; AstraZeneca, Israel
  • Qtern [+ Saxagliptin]
    AstraZeneca, Switzerland; AstraZeneca, Estonia; AstraZeneca, Finland; AstraZeneca, Norway; AstraZeneca, Romania; AstraZeneca, Sweden; AstraZeneca, United States; AstraZeneca AB, Greece; AstraZeneca AB, Netherlands; AstraZeneca UK, United Kingdom
  • Qtern 5/10 [+ Saxagliptin]
    AstraZeneca, Australia
  • Qtern 5mg/10mg [+ Saxagliptin]
    AstraZeneca, Austria
  • Xigduo [+ Metformin]
    2care4, Norway; AstraZeneca, Belgium; AstraZeneca, Canada; AstraZeneca, Czech Republic; AstraZeneca, Denmark; AstraZeneca, Estonia; AstraZeneca, Finland; AstraZeneca, Ireland; AstraZeneca, Netherlands; AstraZeneca, Norway; AstraZeneca, Sweden; AstraZeneca, Slovakia; AstraZeneca AB, Greece; AstraZeneca UK, United Kingdom; Farmagon, Norway
  • Xigduo 5mg/1000mg [+ Metformin]
    AstraZeneca, Austria; AstraZeneca, Germany
  • Xigduo 5mg/850mg [+ Metformin]
    AstraZeneca, Austria; AstraZeneca, Germany
  • Xigduo XR [+ Metformin]
    AstraZeneca, Argentina; AstraZeneca, Australia; AstraZeneca, Georgia; AstraZeneca, New Zealand; AstraZeneca, United States
  • Xigduo XR 10mg/1000mg [+ Metformin]
    AstraZeneca, Switzerland; Bristol-Myers Squibb, Israel
  • Xigduo XR 10mg/500mg [+ Metformin]
    AstraZeneca, Switzerland; Bristol-Myers Squibb, Israel
  • Xigduo XR 5mg/1000mg [+ Metformin]
    AstraZeneca, Switzerland; Bristol-Myers Squibb, Israel
  • Xigduo XR 5mg/500mg [+ Metformin]
    AstraZeneca, Switzerland; Bristol-Myers Squibb, Israel

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide